Iran Blinking Over Strait of Hormuz Could Open Key Oil Route Says ExCIA Chief Petraeus Jamie Dimon Signals JPMorgan Chase Could Pursue 20 Billion Acquisition Amid Regulatory Scrutiny Puravankara Acquires 15Acre Bengaluru Land for Housing Project Eyes Rs 2300 Crore Revenue Potential Standard Chartered CEO Apologizes for Controversial Lower Value Human Capital Remark Waterfield Advisors Equities Head Suggests Staggered Accumulation as Macro Concerns Ease European Telecoms CEO Warns of US Dominance in Satellites and AI Citing Starlink Risk GPGI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines WILC Q4 2025 Earnings Solid EPS Despite Absence of Revenue Guidance Stock Dips 336 PCG Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gains GAINI Q1 2026 Earnings EPS Misses Estimates Slightly Note Price Rises RVTY Q1 2026 Earnings EPS Surpasses Estimates Amid Flat Stock Reaction CE Q1 2026 Earnings EPS Falls Short of Estimates Amid Persistent Chemical Sector Headwinds Iron Horse Acquisitions Rights IRHOR Slips Nearly 6 as Rights Trade Near Support Levels TuHURA Biosciences Inc HURA Rises 684 as Price Tests Key Resistance Level Fortuna Mining Corp FSM Surges 444 Analysis of Key Levels and Outlook WF International WXM Edges Higher Resistance and Support Levels in Focus XMAX Inc XWIN Holds Steady at 824 as Market Awaits Catalyst AMTX Aemetis Q1 loss widens more than expected as revenue drops 22 yearoveryear shares fall 37 How Sachem SACHA manages counterparty exposure SACHA Q4 Earnings Sachem Declares 775 Preferred Dividend The labor dynamics in International IBOC results Q4 2025 Profit Surprises VCX Fundrise leadership outlines retail alternative investment growth plans following latest quarterly earnings release RITR Reitar reports quiet quarter as management highlights operational efficiency strategic priorities amid sector challenges Global Ube Market Surge and Supply Chain Constraints Analysis ATT CEO Highlights BlueCollar Worker Shortage Amid AIDriven Economic Shift SO Q1 2026 Earnings Earnings Per Share Beat Estimates Amid Steady Utility Performance Trevi Therapeutics TRVI Shows Potential as Shares Climb Over 2